The Broad Institute of the Massachusetts Institute of Technology and Harvard is using cloud computing to vastly scale up its genomic research. In a paper published in Nature on Wednesday, researchers at MIT and Harvard describe how they used an IBM BlueGene/Q supercomputer that was built for research purposes but now has been repurposed as a “@@ Mayo added that cloud computing had reduced genome processing costs from $45 to $5, and also freed up IT staff to support the migration of work to the cloud.
The Broad Institute of the Massachusetts Institute of Technology and Harvard is using cloud computing to vastly scale up its genomic research. CIO William Mayo said around half the 70 petabytes of data the organisation handles is on the public cloud, while the technology is more easily and securely shared between Broad and its partners, which include IBM, Amazon Web Services, Microsoft and AliCloud. Mayo added that cloud computing had reduced genome processing costs from $45 to $5, and also freed up IT staff to support the migration of work to the cloud.